» Articles » PMID: 6358558

Staging Laparotomy in Early Ovarian Cancer

Overview
Journal JAMA
Specialty General Medicine
Date 1983 Dec 9
PMID 6358558
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Systematic restaging was performed prospectively in 100 patients referred to the Ovarian Cancer Study Group institutions with a diagnosis of "early" (stage Ia-IIb) ovarian cancer. Before referral, only 25% of patients had an initial surgical incision that was adequate to allow complete examination of the pelvis and abdominal cavity. In patients referred to member institutions, 31 (31%) of 100 were found to have a more advanced stage and 23 (77%) of 31 of these actually had stage III disease. Sixty-one percent of the patients had their advanced stage detected by procedures other than a second laparotomy-nine (29%) of 31 by peritoneoscopy, six (19%) of 31 by peritoneal washings, and six (19%) of 31 by lymphangiography. Sites of unsuspected disease are most likely to be pelvic peritoneum, ascites fluid, other pelvic tissue, para-aortic nodes, and the diaphragms. Based on these data, we conclude that the initial staging approaches traditionally used in clinical evaluation of patients with early ovarian cancer are often incomplete and inadequate.

Citing Articles

The Role of Douglasectomy Instead of Random Biopsies in the Surgical Treatment of Presumed FIGO Stage I Ovarian Cancer.

Tsolakidis D, Zouzoulas D, Tzitzis P, Sofianou I, Theodoulidis V, Chatzistamatiou K Cancers (Basel). 2025; 17(3).

PMID: 39941788 PMC: 11816186. DOI: 10.3390/cancers17030419.


Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic profiling.

Dhar C, Ramachandran P, Xu G, Pickering C, Caval T, Wong M Br J Cancer. 2024; 130(10):1716-1724.

PMID: 38658783 PMC: 11091186. DOI: 10.1038/s41416-024-02644-4.


The impact of lymphadenectomy on ovarian clear cell carcinoma: a systematic review and meta-analysis.

Liu Y, Geng F, Zhang H, Xue J, Chu R World J Surg Oncol. 2024; 22(1):37.

PMID: 38287354 PMC: 10823682. DOI: 10.1186/s12957-024-03324-6.


Hereditary breast and ovarian cancer triggered by occult fallopian tube cancer: a case report.

Murakami H, Fujiwara S, Nishie R, Ueda S, Terada S, Yamada T J Med Case Rep. 2023; 17(1):351.

PMID: 37592269 PMC: 10436669. DOI: 10.1186/s13256-023-04095-6.


A chemotherapy response prediction model derived from tumor-promoting B and Tregs and proinflammatory macrophages in HGSOC.

Xi Y, Zhang Y, Zheng K, Zou J, Gui L, Zou X Front Oncol. 2023; 13:1171582.

PMID: 37519793 PMC: 10382026. DOI: 10.3389/fonc.2023.1171582.